Sam Salman is the Chairman and CEO of Huminn. Huminn is a leading innovation company developing transformative solutions to address persistent global challenges in human health, sustainable food production, and agriculture. In addition to his management role with Huminn, Mr. Salman also serves or has served the following companies in the indicated capacity:

Current Chairman & CEO, Huminn, a disruptive innovations company confronting and addressing unmet needs in health, wellness, and sustainable development.

Current CEO, miR Scientific LLC, a breakthrough molecular and liquid biopsy diagnostic, prognostic, and therapeutic optimization company.

Current, Member of the Board of Trustees and Board of Selectors of Multiplying Good.

Current Co-Founder and Chairman of NRS Informatics LLC, a data and statistical science company applying to facilitate signal processing in complex systems, measuring impact for applications and advancing applications for breakthroughs in molecular science, materials science, and biophysics.

Past President & CEO, Mission Markets, Inc., a pioneering financial services firm focused on impact and sustainability markets.

Past Director, The Baeza Group, a leading Hispanic-focused investment bank – launched the highly successful, Spanish language V-me Television Network in conjunction with the New York City PBS affiliate, WNET.

Mr. Salman was raised in the United Kingdom and is fluent in English, French, Farsi, and has a working knowledge of Hebrew. He was educated at Macalester College in St. Paul, MN, USA, and at the American University of Paris in France.

Eli Mor, Huminn H&W’s President, Head of International, is in charge of its international operations and leads the day-to-day operations of its Israeli-based platforms. He previously served as Chief Financial Officer and Senior Vice President of Huminn Associates’ strategic advisory client, BioHarvest. Prior to BioHarvest, he was the COO & CFO of Explay Ltd. from 2006 to 2008, a leading company in nano-projection technology.

Prior to that, Mr. Mor held various positions at Terayon Communications systems from 2000 to 2006, as General Manager for EMEA, Vice President of Sales for EMEA and Vice President of Finance. Mr. Mor is a Chartered Accountant and holds a B.A. in Finance and Accounting from the Tel-Aviv College of Management.

‍

Dr. Eyal Emmanuel is a scientist, entrepreneur, and C-level manager within the Ag tech, biotech, and life science industries.

‍

Eyal holds a Ph.D. and an MSc from the Weizmann Institute’s Department of Plant Science and a BSc from the Hebrew University of Jerusalem, Faculty of Agriculture, and an M.B.A. from the College of Management, majoring in Bio-Medical Management.

‍

Served as the VP of Ideation and technology evaluation of Yissum, the technology transfer office of the Hebrew University, and  various managerial R&D positions, leading several of Evogene’s core research programs, including being the company Chief Science Officer.

‍

In addition to his roles in Plantae ,Eyal roles as the chairman of the CRISPRIL consortium and  a core member at the Global-future council for synthetic biology the world economic forum.

‍

Vast experience in accounting, finance, tax and legal, including senior finance roles at MOST Software Technologies, Terayon and SPL Software.

Expert in global Regulatory Affairs with experience in Medical Device R&D and QA. Established record in world-wide regulatory strategy for innovative products. Held corporate positions in IMI, Alere and Abbott.

‍

Experienced Vice President Quality Assurance with a demonstrated history of establishing and maintaining effective and efficient quality systems in highly regulated markets. Track record in teams building under fast growing business operations.Holds a Bachelor degree in Biotechnology.